ARAF antibody (AA 210-290)
Quick Overview for ARAF antibody (AA 210-290) (ABIN7221906)
Target
See all ARAF AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 210-290
-
Purpose
- A-Raf Polyclonal Antibody
-
Specificity
- A-Raf Polyclonal Antibody detects endogenous levels of A-Raf protein.
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen
-
Immunogen
- Synthesized peptide derived from the Internal region of human A-Raf at AA range: 210-290
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB (1:500-1:2000), ELISA (1:20000). Not yet tested in other applications.
-
Comment
-
Primary Antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS containing 50 % Glycerol, 0.5 % BSA and 0.02 % Sodium Azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
-
-
- ARAF (V-Raf Murine Sarcoma 3611 Viral Oncogene Homolog (ARAF))
-
Alternative Name
- A-Raf
-
Background
- Rabbit Anti-A-Raf Polyclonal Antibody,ARAF, ARAF1, PKS, PKS2, Serine/threonine-protein kinase A-Raf, Proto-oncogene A-Raf, Proto-oncogene A-Raf-1, Proto-oncogene Pks,This ARAF proto-oncogene belongs to the RAF subfamily of the Ser/Thr protein kinase family, and maybe involved in cell growth and development. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.,serine threonine-protein kinase A-Raf
-
Gene ID
- 369
-
UniProt
- P10398
-
Pathways
- MAPK Signaling, RTK Signaling, Hepatitis C
Target
-